Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Enterprise Value (2016 - 2026)

Creative Medical Technology Holdings has reported Enterprise Value over the past 16 years, most recently at -$7.2 million for Q4 2025.

  • Quarterly Enterprise Value fell 21.17% to -$7.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.2 million through Dec 2025, down 21.17% year-over-year, with the annual reading at -$7.2 million for FY2025, 21.17% down from the prior year.
  • Enterprise Value was -$7.2 million for Q4 2025 at Creative Medical Technology Holdings, down from -$5.4 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$158588.0 in Q2 2021 and troughed at -$22.9 million in Q2 2022.
  • The 5-year median for Enterprise Value is -$7.6 million (2024), against an average of -$9.3 million.
  • Biggest five-year swings in Enterprise Value: tumbled 14317.02% in 2022 and later soared 81.16% in 2023.
  • Tracing CELZ's Enterprise Value over 5 years: stood at -$10.7 million in 2021, then tumbled by 71.57% to -$18.4 million in 2022, then soared by 81.16% to -$3.5 million in 2023, then tumbled by 71.35% to -$5.9 million in 2024, then dropped by 21.17% to -$7.2 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$7.2 million, -$5.4 million, and -$6.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.